DUBLIN, 24 Gashyantare 2022– (BUSINESS WIRE) –Ubushinwa "Isoko rya Vitro Isuzumabumenyi, Ingano, Iteganyagihe 2022-2027, Imigendekere yinganda, Gukura, Gusangira, Ingaruka za COVID-19, Isesengura ryamasosiyete" raporo yongeweho mubushakashatsiAndMarkets. ituro rya com.
Isoko ry’Abashinwa In-vitro (IVD) ni ryo shingiro ry’itangwa ry’ubuvuzi ku isi yose, bikaba bivugwa ko mu mwaka wa 2027. Amadolari ya Amerika miliyoni 18.9 y’amadolari y’Amerika. ubuvuzi.
Igitangaje, mu myaka yashize, umuvuduko w’ubukungu bw’Ubushinwa wabaye mwiza, bituma ubukungu bwiyongera muri GDP ku mwaka.Byongeye kandi, imiterere yubushinwa IVD yagiye igenzurwa namateka manini mpuzamahanga, hamwe nibikoresho bike byo murugo hamwe nabatanga ibicuruzwa.Byongeye kandi, ushakisha impinduka, isosiyete yatangije ibona ubwihindurize bwibikorwa byo gusuzuma kandi ikanagaragaza ko byihuta kubimenyetso byinshi bishingiye kumaraso.
Ubushinwa Muri-Vitro Gusuzuma Inganda ziraguka hamwe na CAGR y'imibare ibiri ya 16.9% mugihe cya 2021-2027
Inganda za IVDs zo mu Bushinwa ziratera imbere mu myaka kandi zifite ubushakashatsi n’ibanze ku isi.Mu Bushinwa, hakenewe ivuriro rikenewe kugira ngo imishinga ikomeze itere imbere.Nyamara, ibisabwa bishya byo kwisuzumisha bigenda bigaragara, bisaba laboratoire zubuvuzi gukora indi mishinga yo gupima hamwe ninganda za IVD gukora tekinolojiya nibicuruzwa bishya.Byongeye kandi, hamwe n’imibereho myiza y’Abashinwa n’umuvuduko ukabije w’abaturage b’Ubushinwa, icyifuzo cyo gucunga ubuzima bw’umuryango kiriyongera;iyi nzira rero izahinduka ingingo yingenzi yo gukura mubikorwa bya vitro yo gusuzuma.
Uburyo Coronavirus Yungukiye Mubushinwa Muri Vitro Gusuzuma Isoko ryiterambere
COVID-19 yihutishije iterambere ry’inganda zipima In-vitro mu Bushinwa.Nkuko Ubushinwa bwakomeje politiki ya COVID zero, niko kugirango bigerweho umubare munini wibizamini bya PCR hamwe na Rapid Antigen bigomba gukorwa.Bitewe na COVID ihindagurika nka Alpha, Beta, Gamma Delta, Delta Plus, na Omnicorn iherutse, ikizamini cya PCR hamwe na Rapid Antigen bizakomeza kubaho ku bwinshi.Nk’uko byatangajwe, Ubushinwa In-Vitro Diagnostics Ingano y’isoko yari miliyari 7.4 US $ mu 2021.
Molecular Diagnostics Segment Yandika Kwiyongera Gukomeye
Muri raporo, isoko ryashyizwe mu byiciro bya chimie clinique, Immunoassay, Molecular Diagnostic, Microbiology, Hematology, no Kwikurikiranira hafi Amaraso Glucose (SMBG), Point of Care Testing (POCT), na Coagulation.Muri IVD, imwe mu majyambere yingenzi yabaye muburyo bwibikoresho byo gusuzuma.Nkuko bigaragazwa nisesengura, polymerase urunigi ni rwo rusanzwe rwambere rwo gusuzuma molekile.
Byongeye kandi, ibicuruzwa nyabyo bya PCR icyarimwe bigaragaza icyarimwe virusi, bagiteri, ibihumyo, na parasite, bigatuma laboratoire ya molekile igabanya ibiciro kandi igatanga umusaruro ushimishije mugupima molekile.Igitangaje, ibizamini byo kwisuzumisha bikoreshwa mugutahura urutonde rwihariye muri ADN cyangwa RNA (harimo nucleotide polymorphism imwe (SNP), gusiba, guhinduranya ibintu, gushiramo, nibindi) bishobora kuba bitajyanye nindwara iyo ari yo yose.
Abakinnyi b'ingenzi mu Isoko rya IVD
Ibigo bikomeye mpuzamahanga bya IVD bimaze kugira uruhare runini ku isoko ry’Ubushinwa kandi byerekana inzitizi zishobora guhatanira abinjira mu isoko.Abakinnyi b'ingenzi barimo Roche Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories, Danaher Corporation, na bioMerieux SA.
Isosiyete yishimira umutungo munini cyane kugirango igure ikiguzi kijyanye no kwemeza ibicuruzwa, ibizamini byo kwa muganga, no guhagararira abakozi.Byongeye kandi, ayo masosiyete arashobora gukora ibyakenewe kugirango hashyizweho isaranganya ritaziguye hamwe n’ibikorwa by’inganda.
Ibice bitwikiriye
Isoko rya Chimie Isoko
Isoko rya Immunoassay
Isoko ryo Gusuzuma Isoko
Isoko rya Microbiology
Isoko rya Hematology
Kwikurikiranira hafi Amaraso Glucose (SMBG) Isoko
Ingingo yo Kwipimisha (POCT) Isoko
Isoko rya Coagulation
Igihe cyo kohereza: Werurwe-11-2022